RNAC — Cartesian Therapeutics Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Cartesian Therapeutics Inc.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupu… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$7.38
Market Cap$221M
Float9.6M
Shares Outstanding29.4M
P/E (Forward)25.06
Price/Sales (TTM)124.48
vs. Analyst Target+372.3% to analyst PT
Operating Margin (TTM)-33973.08%
Revenue (TTM)$1.8M
Earnings Growth (YoY)-7.40%
Dividend RateNone
Analyst Target Price$34.86 (8 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $16.6M -$68.9M $16.6M -$65.6M
2021 $85.1M -$25.7M $85.1M -$5.2M
2022 $111M $35.4M $109M $39.8M
2023 $26.0M -$220M $26.0M -$235M
2024 $38.9M -$77.4M $38.9M -$76.0M
2025 $2.8M -$130M $2.8M -$86.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $298,000 $15.9M
Sep 2025 $452,000 -$35.9M
Dec 2025 $947,000 -$92.6M
Mar 2026 $78,000 -$39.2M

Ownership & Float

Insider Ownership53.7%
Institutional Ownership25.2%
Short Float22.6%
% of All Funds Holding0.94%
Number of Funds Holding77

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$6.80Near-term / short-term trend
Weekly40-Week SMA$7.90Medium-term trend
Weekly80-Week SMA$11.45Cyclical trend (business cycle)
Weekly200-Week SMA$24.43Secular trend (multi-year)
Monthly10-Month SMA$7.73Near-term monthly trend
Monthly20-Month SMA$11.50Medium-term monthly trend
Monthly40-Month SMA$20.46Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$7.40 resistance 2.27x 1 months ago
$10.10 resistance 1.68x 6 months ago
$26.50 resistance 3.36x 21 months ago
$35.00 resistance 2.27x 22 months ago

Historical Earnings Reactions (40 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.11% -0.08% 45.00% 11.54% -11.00%
1 Day -2.69% -1.54% 32.50% 21.45% -54.02%
1 Week -1.44% -1.61% 45.00% 48.48% -58.99%
2 Weeks -0.63% -4.56% 42.50% 45.00% -56.50%
1 Month 0.13% 2.12% 56.41% 66.33% -55.35%

Next earnings: May 14, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan5.7%50.0%10
Feb1.3%60.0%10
Mar-10.1%40.0%10
Apr-7.8%40.0%10
May15.6%66.7%9
Jun5.5%44.4%9
Jul-7.5%30.0%10
Aug5.5%70.0%10
Sep1.6%50.0%10
Oct-2.0%50.0%10
Nov-3.0%50.0%10
Dec-10.8%20.0%10

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.05% 46.3% 464
Tuesday -0.29% 45.8% 511
Wednesday 0.20% 48.4% 508
Thursday 0.02% 46.8% 500
Friday 0.17% 44.7% 501

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 25.2%

Insider Transactions — Smart Summary

Total insider ownership: 53.7%

12-Month Insider Activity Summary

Total Filings4
Net Value-$258,671.221
Net Shares Change-7,930
% of Float-0.1%
C-Suite Filings3
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
BARABE TIMOTHY C +$205,797 1 1 buy
Brunn Carsten President and CEO -$162,076.99 1 1 sell
Davis Blaine Chief Financial Officer -$72,227.443 1 1 sell
Miljkovic Milos Chief Medical Officer -$24,366.788 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-01-08 – 2026-01-08 3 3 -$258,671.221 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-12-08 BARABE TIMOTHY C +$205,797 Transaction at $6.86, now +7.6%
2026-01-08 Miljkovic Milos Chief Medical Officer -$24,366.788 Transaction at $6.82, now +8.2%
2026-01-08 Davis Blaine Chief Financial Officer -$72,227.443 Transaction at $6.82, now +8.2%
2026-01-08 Brunn Carsten President and CEO -$162,076.99 Transaction at $6.82, now +8.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Cartesian Therapeutics Inc. (RNAC) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for RNAC on Trend Edge →